Embolization and Coiling Devices - Medical Devices Pipeline Assessment, 2017

2017-06-01
Price :
Published : Jun-2017
No. of Pages : 117

Table of Contents

1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6

2 Introduction 7
2.1 Embolization and Coiling Devices Overview 7

3 Products under Development 8
3.1 Embolization and Coiling Devices - Pipeline Products by Stage of Development 8
3.2 Embolization and Coiling Devices - Pipeline Products by Segment 9
3.3 Embolization and Coiling Devices - Pipeline Products by Territory 10
3.4 Embolization and Coiling Devices - Pipeline Products by Regulatory Path 11
3.5 Embolization and Coiling Devices - Pipeline Products by Estimated Approval Date 12
3.6 Embolization and Coiling Devices - Ongoing Clinical Trials 13

4 Embolization and Coiling Devices - Pipeline Products under Development by Companies 14
4.1 Embolization and Coiling Devices Companies - Pipeline Products by Stage of Development 14
4.2 Embolization and Coiling Devices - Pipeline Products by Stage of Development 15

5 Embolization and Coiling Devices Companies and Product Overview 16
5.1 Aneuclose LLC Company Overview 16
5.1.1 Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 Avantec Vascular Corporation Company Overview 17
5.2.1 Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 BioCure, Inc. Company Overview 18
5.3.1 BioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
5.4 Collagen Matrix Inc Company Overview 19
5.4.1 Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 19
5.5 DePuy Synthes Inc Company Overview 20
5.5.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 20
5.6 Insera Therapeutics, LLC Company Overview 21
5.6.1 Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 21
5.7 Medtronic plc Company Overview 22
5.7.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 22
5.8 MicroPort Scientific Corp Company Overview 26
5.8.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26
5.9 MicroVention, Inc. Company Overview 29
5.9.1 MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
5.10 MiVi Neuroscience, LLC Company Overview 35
5.10.1 MiVi Neuroscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 35
5.11 Neuravi Ltd Company Overview 36
5.11.1 Neuravi Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
5.12 Shape Memory Therapeutics, Inc. Company Overview 40
5.12.1 Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.13 Taewoong Medical Co Ltd Company Overview 41
5.13.1 Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
5.14 Terumo Corp Company Overview 43
5.14.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 43
5.15 University of California Los Angeles Company Overview 44
5.15.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 44
5.16 University of Minnesota Company Overview 45
5.16.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 45
5.17 University of Wisconsin Madison Company Overview 46
5.17.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 46
5.18 Valor Medical Inc Company Overview 47
5.18.1 Valor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 47
5.19 Vascular Solutions Inc Company Overview 48
5.19.1 Vascular Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 48

6 Embolization and Coiling Devices- Recent Developments 49
6.1 May 09, 2017: Penumbra Reports First Quarter 2017 Financial Results 49
6.2 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 49
6.3 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 50
6.4 Apr 25, 2017: Stryker reports first quarter 2017 results 51
6.5 Apr 21, 2017: Penumbra Appoints Bridget O'Rourke to its Board of Directors 52
6.6 Apr 19, 2017: Johnson & Johnson reports Q1 2017 results 53
6.7 Apr 18, 2017: Johnson & Johnson Reports 2017 First-Quarter Results 55
6.8 Mar 30, 2017: MPSC Announces 2016 Annual Results 57
6.9 Mar 07, 2017: MicroVention And Terumo Announce Data From Multicenter GREAT Study 58
6.10 Feb 28, 2017: Penumbra Reports Fourth Quarter and Full Year 2016 Financial Results 59
6.11 Feb 21, 2017: Neuravi Announces Completion of Patient Enrollment in Clinical Trial of a Novel Stent Retriever for Acute Ischemic Stroke 60
6.12 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 61
6.13 Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016 64
6.14 Feb 09, 2017: Terumo Announces Change of Executive Officers 65
6.15 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 66
6.16 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 67
6.17 Jan 31, 2017: Terumo Opens a Branch in Yangon 68
6.18 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 68
6.19 Jan 24, 2017: Johnson & Johnson Reports 2016 Fourth-Quarter Results 70
6.20 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 72
6.21 Jan 09, 2017: Johnson & Johnson Medical Devices Companies Launch CareAdvantage, a Suite of Holistic, Insights-Driven Capabilities to Help U.S. Health Systems Navigate Value-Based Care 74
6.22 Dec 19, 2016: Penumbra Appoints Thomas C. Wilder to its Board of Directors 75
6.23 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy 75
6.24 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 76
6.25 Nov 22, 2016: Collagen Matrix Names Oystein Valberg as Chief Financial Officer 79
6.26 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 79
6.27 Nov 15, 2016: Penumbra Announces Resignation of Board Member 80
6.28 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 80
6.29 Nov 03, 2016: Penumbra Reports Third Quarter 2016 Financial Results 81
6.30 Oct 27, 2016: Stryker reports third quarter 2016 results 81
6.31 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 83
6.32 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 84
6.33 Oct 24, 2016: Vascular Solutions Reports Third Quarter Results 85
6.34 Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results 88
6.35 Oct 14, 2016: Medtronic Announces Voluntary Recall of Its Pipeline Embolization Device, Alligator Retrieval Device, X-Celerator Hydrophilic Guidewire, Ultraflow and Marathon Flow Directed Micro Catheters 89
6.36 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 90
6.37 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 91
6.38 Sep 07, 2016: Neuravi Announces European Launch of EmboTrap II Stent Retriever for the Treatment of Acute Stroke 92
6.39 Aug 30, 2016: MPSC Announces 2016 Interim Results 93
6.40 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 94
6.41 Aug 09, 2016: Penumbra Reports Second Quarter 2016 Financial Results 97
6.42 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 97
6.43 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016 99
6.44 Jul 26, 2016: Merit Medical Announces Appointment of New Director 100
6.45 Jul 25, 2016: Vascular Solutions Reports Second Quarter Results 100
6.46 Jul 25, 2016: Neuravi Selects Robert Colloton to Lead U.S. Commercialization of Innovative Stent Retriever 103
6.47 Jul 21, 2016: Stryker reports second quarter 2016 results 104
6.48 Jul 19, 2016: Johnson & Johnson Reports 2016 Second-Quarter Results 105
6.49 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 107
6.50 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 107
6.51 Jun 24, 2016: Collagen Matrix Names Bill Messer as Vice President, Sales and Marketing 108
6.52 Jun 22, 2016: Johnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice President of Investor Relations 108
6.53 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 109
6.54 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 109
6.55 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 110

7 Appendix 114
7.1 Methodology 114
7.2 About GlobalData 117
7.3 Contact Us 117
7.4 Disclaimer 117

List of Tables

Table 1: Embolization and Coiling Devices - Pipeline Products by Stage of Development 8
Table 2: Embolization and Coiling Devices - Pipeline Products by Segment 9
Table 3: Embolization and Coiling Devices - Pipeline Products by Territory 10
Table 4: Embolization and Coiling Devices - Pipeline Products by Regulatory Path 11
Table 5: Embolization and Coiling Devices - Pipeline Products by Estimated Approval Date 12
Table 6: Embolization and Coiling Devices - Ongoing Clinical Trials 13
Table 7: Embolization and Coiling Devices Companies - Pipeline Products by Stage of Development 14
Table 8: Embolization and Coiling Devices - Pipeline Products by Stage of Development 15
Table 9: Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 16
Table 10: Janjua Aneurysm Net - Product Status 16
Table 11: Janjua Aneurysm Net - Product Description 16
Table 12: Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 17
Table 13: Endovascular Embolization Device - Product Status 17
Table 14: Endovascular Embolization Device - Product Description 17
Table 15: BioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
Table 16: GelCoil - Product Status 18
Table 17: GelCoil - Product Description 18
Table 18: Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 19
Table 19: Collagen-based Coils - Product Status 19
Table 20: Collagen-based Coils - Product Description 19
Table 21: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 20
Table 22: Liquid Embolic System - Product Status 20
Table 23: Liquid Embolic System - Product Description 20
Table 24: Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 21
Table 25: SHELTER - Product Status 21
Table 26: SHELTER - Product Description 21
Table 27: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 22
Table 28: Medina Embolization Device - Product Status 22
Table 29: Medina Embolization Device - Product Description 22
Table 30: UNO Neurovascular Embolization System - Product Status 23
Table 31: UNO Neurovascular Embolization System - Product Description 23
Table 32: Medtronic plc - Ongoing Clinical Trials Overview 24
Table 33: Medina Embolization Device - Medina Embolization Device in Neurovascular Aneurysms Study - A Post Market Clinical Follow-up Study: The MEDINA Study 25
Table 34: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26
Table 35: Embolization Coils - Product Status 26
Table 36: Embolization Coils - Product Description 26
Table 37: MicroPort Scientific Corp - Ongoing Clinical Trials Overview 27
Table 38: Embolization Coils - Prospective, Randomized, Controlled, Open Label, All China, Multi-center, Registration Trial of the Microport Neurotech Coil Embolization System for the Treatment of Intracranial Aneurysms 28
Table 39: MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
Table 40: Advanced Coil - Product Status 29
Table 41: Advanced Coil - Product Description 29
Table 42: Advanced WEB Aneurysm Embolization Device - Product Status 30
Table 43: Advanced WEB Aneurysm Embolization Device - Product Description 30
Table 44: WEB Aneurysm Embolization System - Product Status 30
Table 45: WEB Aneurysm Embolization System - Product Description 31
Table 46: MicroVention, Inc. - Ongoing Clinical Trials Overview 32
Table 47: WEB Aneurysm Embolization System - Clinical Assessment of Web Device in Ruptured Aneurysms 33
Table 48: WEB Aneurysm Embolization System - CLinical Assessment of WEB Device in Ruptured aneurysms (CLARYS): CLARYS 33
Table 49: WEB Aneurysm Embolization System - The WEB Intrasaccular Therapy Study (WEB-IT) 33
Table 50: WEB Aneurysm Embolization System - WEB Clinical Assessment of IntraSaccular Aneurysm Therapy 34
Table 51: WEB Aneurysm Embolization System - WEB French Observatory 34
Table 52: MiVi Neuroscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 35
Table 53: Neuronet - Product Status 35
Table 54: Neuronet - Product Description 35
Table 55: Neuravi Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
Table 56: EmboTrap II Revascularization Device - Product Status 36
Table 57: EmboTrap II Revascularization Device - Product Description 36
Table 58: EmboTrap Revascularization Device - Product Status 37
Table 59: EmboTrap Revascularization Device - Product Description 37
Table 60: Neuravi Ltd - Ongoing Clinical Trials Overview 38
Table 61: EmboTrap Revascularization Device - A.R.I.S.E. Analysis of Revascularisation in Ischemic Stroke with EmboTrap: Post Marketing Observational Study of CE Marked EmboTrap Mechanical Thrombectomy Device 39
Table 62: EmboTrap Revascularization Device - ARISE II (Analysis of Revascularization in Ischemic Stroke with EmboTrap) Study 39
Table 63: Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
Table 64: Neurovascular Embolization System - Product Status 40
Table 65: Neurovascular Embolization System - Product Description 40
Table 66: Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
Table 67: K3 Platium Coil - Product Status 41
Table 68: K3 Platium Coil - Product Description 42
Table 69: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 43
Table 70: VFC /Hydrofill Coil - Product Status 43
Table 71: VFC /Hydrofill Coil - Product Description 43
Table 72: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 44
Table 73: Bioactive Endovascular Coil - Product Status 44
Table 74: Bioactive Endovascular Coil - Product Description 44
Table 75: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 45
Table 76: Vascular Embolization Catheter - Product Status 45
Table 77: Vascular Embolization Catheter - Product Description 45
Table 78: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 46
Table 79: Bioactive Endovascular Device - Product Status 46
Table 80: Bioactive Endovascular Device - Product Description 46
Table 81: Valor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 47
Table 82: Neucrylate AN - Product Status 47
Table 83: Neucrylate AN - Product Description 47
Table 84: Vascular Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 48
Table 85: Embolization Device - Product Status 48
Table 86: Embolization Device - Product Description 48
Table 87: Glossary 116

List of Figures

Figure 1: Embolization and Coiling Devices - Pipeline Products by Stage of Development 8
Figure 2: Embolization and Coiling Devices - Pipeline Products by Segment 9
Figure 3: Embolization and Coiling Devices - Pipeline Products by Territory 10
Figure 4: Embolization and Coiling Devices - Pipeline Products by Regulatory Path 11
Figure 5: Embolization and Coiling Devices - Pipeline Products by Estimated Approval Date 12
Figure 6: Embolization and Coiling Devices - Ongoing Clinical Trials 13

Filed in: Medical Device
Publisher : GlobalData